Differential Diagnosis of Major Depressive Disorder and Bipolar Disorder: Genetic and Hormonal Assessment and the Influence of Early-Life Stress

• Published in: Brain sciences Vol. 12; no. 11; p. 1476
• Main Authors: Menezes, Itiana Castro, von Werne Baes, Cristiane, Fígaro-Drumond, Fernanda Viana, Dias Macedo, Brisa Burgos, Bueno, Ana Carolina, Lacchini, Riccardo, Feijó de Mello, Marcelo, de Castro, Margaret, Juruena, Mario Francisco
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 31-10-2022; MDPI
• Subjects: Aldosterone; Angiotensin; biomarker; Biomarkers; bipolar; Bipolar disorder; Child development; Cortisol; Data analysis; depression; Differential diagnosis; Gene polymorphism; Genes; Genetic analysis; glucocorticoid receptor (GR); Hormones; Hypothalamic-pituitary-adrenal axis; Hypothalamus; Mental depression; Mental disorders; mineralocorticoid receptor (MR); Neurological disorders; Pituitary; polymorphism (SNP); Renin; Sample size; Software; United States > US
• ISSN: 2076-3425; 2076-3425
• DOI: 10.3390/brainsci12111476

Few studies have assessed biomarkers for the differentiation of major depressive disorder (MDD) and bipolar disorder (BD). However, some elements of depression such as hormones and receptors of the renin–angiotensin–adrenal system (RAAS), the hypothalamus–pituitary–adrenal (HPA) axis, and history of early-life stress (ELS) could be considered for differential diagnosis. Therefore, this study aimed to assess aldosterone and cortisol levels, MR and GR gene polymorphisms, and ELS as potential biomarkers for differentiating MDD and BD. This study presents a case–control design. Groups comprised samples for genetic, cortisol, and aldosterone analysis: healthy control (HC; n = 113/97/103), MDD (n = 78/69/67) and BD (n = 82/68/65) subjects. Furthermore, all subjects were assessed for diagnostic screening, the severity of depression, and history of ELS by applying MINI-PLUS, GRID-HDRS, and CTQ, respectively. In addition, genotype and allelic frequencies of GR (N363S, R22/23K and BclI) and MR (MI180V and -2G/C) polymorphisms were evaluated via PCR. Our findings demonstrate that basal aldosterone levels may be a biomarker for differentiating BD and MDD. Furthermore, ELS affects the HPA axis in BD, cortisol may be considered a biomarker for distinguishing BD and MDD, but only in the absence of ELS, and, finally, history of ELS and MR-2G/C variant alleles are factors that contribute to the severity of depressive symptoms in MDD and BD.